Draft:RightBio Metrics

= RightBio Metrics = RightBio Metrics is a medical device company that provides technology that is used in medical practices for the accurate placement of nasogastric and orogastric tubes. The company has indicated that its primary goal is to reduce harm caused by misplaced NG/OG tubes through biofluid measurement solutions.

History and Development
RightBio Metrics was founded in 2005 by Paul Gilbert, MD and Robert Gilbert, MD. The company is primarily known for the development of the RightSpotpH® Indicator, which was launched in 2011. The device introduced a new method for verifying nasogastric and orogastric tube placement via pH.

RightSpotpH® Indicator
The RightSpotpH® Indicator is a medical device designed for verifying the correct placement of nasogastric and orogastric tubes. It functions based on pH measurement, providing an enclosed system for healthcare professionals to determine that a tube has been placed into the patient’s stomach successfully. The device aims to reduce risks imposed by traditional tube confirmation methods such as auscultation. In a study published by the National Library of Medicine, it was found that "The RightSpotpH™ indicator is sensitive and specific for determination of intragastric pH determination as less than or greater than 4.5 as commonly used for nasogastric tube placement."

Applications in Medical Practice
Indicated for neonates, pediatrics, and adults, the RightSpotpH® Indicator's use is intended to ensure the safety and accuracy of nasogastric and orogastric tube placement, a common procedure in hospital settings and an important aspect of intensive care situations. Correct placement helps prevent procedural risks resulting from improper tube placement, such as aspiration pneumonia.

Research and Clinical Studies Regarding The RightSpotpH® Indicator & pH Testing
Research published in the National Library of Medicine suggests the effectiveness of the RightSpotpH® Indicator in neonatal settings, describing its potential role in clinical outcomes. A clinical study published in The Journal of Perinatal & Neonatal Nursing on enteral tube placement discusses the significance of accurate tube placement and the role of pH measurement. An NCBI study on feeding tube placement supports the importance of precise placement techniques, providing support for pH-based verification methods.

Guidelines and Safety Standards
The National Patient Safety Agency (NPSA) in the UK has set guidelines on tube placement that have informed the development and application of the RightSpotpH® Indicator. The NHS has issued guidelines and safety alerts on nasogastric tube placement, stressing the need for verification technologies. Perspectives from the AACN on critical care nursing have addressed the challenges in feeding tube placement.

Patient Safety and Clinical Impact
Assessments of patient safety risks in tube placement from the Children's Hospital Association highlight the necessity of reliable verification methods. The article presents pH testing as a reliable method for testing the accuracy of NG tube placement.

Regulatory Approvals and Compliance
RightBio Metrics' RightSpotpH® Indicator has received FDA approval and is CLIA-waived.

Industry Recognition
RightBio Metrics received the Patient Safety Innovation Award given by the Patient Safety Movement Foundation during the 6th Annual World Patient Safety, Science & Technology Summit held in London, England in 2015. Recognition has been given to RightBio Metrics by the Florida Hospital Tampa Pepin Heart Institute, now known as AdventHealth Tampa, and the University of Florida College of Medicine.